Yi Larson
Overview
Yi Larson received an average of $6M in total compensation, including $240K in salary, at Turning Point Therapeutics from 2019 to 2021. Yi Larson also received $8M at LianBio in 2021.
- 2021
- 2020
- 2019
Turning Point TherapeuticsFormer Executive Vice President and Chief Financial Officer
LianBioChief Financial Officer
Turning Point TherapeuticsFormer Executive Vice President and Chief Financial Officer
Turning Point TherapeuticsFormer Executive Vice President and Chief Financial Officer
Source: SEC filings on April 29, 2022 and April 27, 2022.
Related executives
We found nine more executives who work or worked at Turning Point Therapeutics and LianBio.
Yizhe Wang
LianBio
Chief Executive Officer
Athena Countouriotis
Turning Point Therapeutics
Chief Executive Officer
Debra Yu
LianBio
President & Chief Strategy Officer
Mohammad Hirmand
Turning Point Therapeutics
Chief Medical Officer
Annette North
Turning Point Therapeutics
General Counsel
Paolo Tombesi
Turning Point Therapeutics
Chief Financial Officer
Siegfried PHD
Turning Point Therapeutics
Chief Scientific Officer
Brian Baker
Turning Point Therapeutics